Eduardo J. Salido
University Hospital Of The Canary Islands
Santa Cruz De Tenerife, CN 38320, Spain
Santa Cruz De Tenerife, CN 38320, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 11, 2026
Beta-Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion-Dependent Thalassemia.
Journal: Journal of clinical laboratory analysis
Published: January 19, 2026
Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.
Journal: The Lancet. Oncology
Published: January 11, 2026
Nanobodies as therapies for loss-of-function misfolding diseases: the example of Primary Hyperoxaluria Type 1.
Journal: International journal of biological macromolecules
Published: May 09, 2025
Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis.
Journal: Bone marrow transplantation
Published: July 31, 2024
Human glyoxylate metabolism revisited: New insights pointing to multi-organ involvement with implications for siRNA-based therapies in primary hyperoxaluria.
Journal: Journal of inherited metabolic disease
Published: May 24, 2024
Modulation of the K/BxN arthritis mouse model and the effector functions of human fibroblast-like synoviocytes by liver X receptors.
Journal: European journal of immunology
Published: March 13, 2024
Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects.
Journal: Biomedicines
Published: March 13, 2024
Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants.
Journal: FEBS letters
Published: October 13, 2023
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.
Journal: EMBO molecular medicine
Published: June 28, 2023
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.
Journal: Kidney international reports
Published: May 11, 2023
Last Updated: 09/26/2026